Corcept Therapeutics | CORT - Interest Income


Corcept Therapeutics reported $5.42M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.33M 86K Dec/2025
Aurora Cannabis CAD 1.85M 120K Sep/2025
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
Corcept Therapeutics USD 5.42M 399K Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
J&J USD 2.14 237M Mar/2026
Knight Therapeutics CAD 2.46M 498K Sep/2024
Merck USD 69M 27M Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Pacira USD 2.3M 6.24M Dec/2025
Pfizer USD 115M 51M Mar/2026
Supernus Pharmaceuticals USD 2.02M 254K Dec/2025